ProfileGDS4718 / 229882_at
TitleColorectal cancer: homogenized tumor tissues
OrganismHomo sapiens


no metastasis metastatic recurrence metastasis stage: 0 stage: 1 stage: 2a stage: 2b stage: 3b stage: 3c stage: 2a stage: 2b stage: 3b stage: 3c stage: 4 GSM549121 GSM549102 GSM549104 GSM549108 GSM549119 GSM549133 GSM549139 GSM549099 GSM549109 GSM549110 GSM549114 GSM549122 GSM549134 GSM549136 GSM549140 GSM549111 GSM549113 GSM549132 GSM549137 GSM549142 GSM549100 GSM549107 GSM549115 GSM549116 GSM549120 GSM549131 GSM549118 GSM549129 GSM549123 GSM549124 GSM549126 GSM549128 GSM549103 GSM549117 GSM549138 GSM549141 GSM549130 GSM549101 GSM549105 GSM549106 GSM549112 GSM549125 GSM549127 GSM549135 60% 53% 47% 54% 59% 57% 74% 51% 56% 54% 51% 49% 61% 62% 61% 56% 48% 62% 73% 60% 57% 58% 51% 54% 51% 64% 59% 69% 55% 62% 63% 64% 60% 53% 79% 69% 62% 59% 59% 48% 53% 66% 68% 70% sort by disease state sort by other Gene Expression Profile
Graph caption help
SampleTitleValueRank
GSM549121patient 080, normal, homogenized [OPG study]6.0929560
GSM549102patient 115, normal, homogenized [OPG study]5.6868653
GSM549104patient 119, normal, homogenized [OPG study]5.3146947
GSM549108patient 138, normal, homogenized [OPG study]5.790854
GSM549119patient 077, normal, homogenized [OPG study]6.0655759
GSM549133patient 032, cancer, homogenized [OPG study]5.8762957
GSM549139patient 042, cancer, homogenized [OPG study]7.2466274
GSM549099patient 107, normal, homogenized [OPG study]5.5586451
GSM549109patient 139, normal, homogenized [OPG study]5.8655556
GSM549110patient 046, normal, homogenized [OPG study]5.7640954
GSM549114patient 063, normal, homogenized [OPG study]5.547551
GSM549122patient 082, normal, homogenized [OPG study]5.4812849
GSM549134patient 033, cancer, homogenized [OPG study]6.1551861
GSM549136patient 036, cancer, homogenized [OPG study]6.2683362
GSM549140patient 044, cancer, homogenized [OPG study]6.1534161
GSM549111patient 047, normal, homogenized [OPG study]5.8483456
GSM549113patient 057, normal, homogenized [OPG study]5.3541548
GSM549132patient 031, cancer, homogenized [OPG study]6.261262
GSM549137patient 038, cancer, homogenized [OPG study]7.2203373
GSM549142patient 047, cancer, homogenized [OPG study]6.2132360
GSM549100patient 110, normal, homogenized [OPG study]5.8994857
GSM549107patient 135, normal, homogenized [OPG study]5.9485358
GSM549115patient 068, normal, homogenized [OPG study]5.5164251
GSM549116patient 072, normal, homogenized [OPG study]5.7371254
GSM549120patient 078, normal, homogenized [OPG study]5.5653551
GSM549131patient 030, cancer, homogenized [OPG study]6.4171464
GSM549118patient 074, normal, homogenized [OPG study]6.0749759
GSM549129patient 027, cancer, homogenized [OPG study]6.8513169
GSM549123patient 088, normal, homogenized [OPG study]5.7942555
GSM549124patient 006, cancer, homogenized [OPG study]6.276862
GSM549126patient 015, cancer, homogenized [OPG study]6.3205463
GSM549128patient 025, cancer, homogenized [OPG study]6.4602564
GSM549103patient 117, normal, homogenized [OPG study]6.1436360
GSM549117patient 073, normal, homogenized [OPG study]5.6261853
GSM549138patient 041, cancer, homogenized [OPG study]7.8006679
GSM549141patient 045, cancer, homogenized [OPG study]6.8528469
GSM549130patient 028, cancer, homogenized [OPG study]6.2541462
GSM549101patient 111, normal, homogenized [OPG study]6.0733159
GSM549105patient 128, normal, homogenized [OPG study]6.0559759
GSM549106patient 134, normal, homogenized [OPG study]5.3731348
GSM549112patient 048, normal, homogenized [OPG study]5.6672553
GSM549125patient 011, cancer, homogenized [OPG study]6.5877466
GSM549127patient 024, cancer, homogenized [OPG study]6.8121868
GSM549135patient 035, cancer, homogenized [OPG study]6.9736270